Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:11 pm Purchase | 13G | AbCellera Biologics Inc. ABCL | BAKER BROS. ADVISORS LP | 27,525,640 9.300% | 4,615,887 (+20.15%) | View |
| 2024-02-14 4:21 pm Purchase | 13G | AbCellera Biologics Inc. ABCL | BAKER BROS. ADVISORS LP | 22,909,753 7.900% | 22,909,753 (New Position) | View |
| 2024-02-13 5:01 pm Purchase | 13G | AbCellera Biologics Inc. ABCL | Hansen Carl L. G. | 60,740,524 20.600% | 1,747,217 (+2.96%) | View |
| 2024-01-29 11:47 am Purchase | 13G | AbCellera Biologics Inc. ABCL | BAILLIE GIFFORD & CO | 24,044,796 8.290% | 4,348,061 (+22.08%) | View |
| 2023-04-24 4:53 pm Unchanged | 13D | AbCellera Biologics Inc. ABCL | THIEL PETER | 14,360,427 4.990% | 0 (Unchanged) | View |
| 2023-02-13 2:49 pm Sale | 13G | AbCellera Biologics Inc. ABCL | Capital World Investors | 9,327,493 3.300% | -12,724,210 (-57.70%) | View |
| 2023-02-06 4:31 pm Purchase | 13G | AbCellera Biologics Inc. ABCL | Hansen Carl L. G. | 58,993,307 20.400% | 3,586,608 (+6.47%) | View |
| 2023-01-18 06:35 am Purchase | 13G | AbCellera Biologics Inc. ABCL | BAILLIE GIFFORD & CO | 19,696,735 6.880% | 19,696,735 (New Position) | View |
| 2022-02-14 5:01 pm Sale | 13G | AbCellera Biologics Inc. ABCL | VIKING GLOBAL INVESTORS LP | 0 0.000% | -19,283,744 (Position Closed) | View |
| 2022-02-14 3:24 pm Sale | 13G | AbCellera Biologics Inc. ABCL | DCVC Bio L.P. | 7,305,761 2.600% | -21,800,000 (-74.90%) | View |
| 2022-02-11 2:48 pm Purchase | 13G | AbCellera Biologics Inc. ABCL | Capital World Investors | 22,051,703 7.800% | 22,051,703 (New Position) | View |
| 2022-02-10 4:30 pm Sale | 13G | AbCellera Biologics Inc. ABCL | Hansen Carl L. G. | 55,406,699 19.500% | -6,421,131 (-10.39%) | View |
| 2021-02-16 4:18 pm Purchase | 13G | AbCellera Biologics Inc. ABCL | Hansen Carl L. G. | 61,827,830 23.000% | 61,827,830 (New Position) | View |
| 2021-02-12 8:00 pm Unchanged | 13G | AbCellera Biologics Inc. ABCL | VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% | 0 (Unchanged) | View |
| 2021-02-09 06:24 am Purchase | 13G | AbCellera Biologics Inc. ABCL | DCVC Bio L.P. | 29,105,761 10.800% | 29,105,761 (New Position) | View |
| 2020-12-28 4:48 pm Purchase | 13D | AbCellera Biologics Inc. ABCL | THIEL PETER | 14,360,427 5.300% | 14,360,427 (New Position) | View |
| 2020-12-23 8:37 pm Unchanged | 13G | AbCellera Biologics Inc. ABCL | VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% | 0 (Unchanged) | View |
| 2020-12-21 5:28 pm Purchase | 13G | AbCellera Biologics Inc. ABCL | VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% | 19,283,744 (New Position) | View |